Anxiety Disorder

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01

Comorbid lifetime anxiety disorder was associated with significantly lower smoking abstinence rates at end of treatment compared to no anxiety disorder, among smokers with unipolar depressive disorder

Effect: decline; 23% (18/79) vs 41% (49/120), Chi2=6.9, p<0.01